Annette Dale-Perera

A 30 minute YouTube lecture giving an overview of some International initiatives on quality in drug use disorder treatment services and systems. The lecture is given by Annette Dale-Perera and was filmed in Autumn 2020 by UNODC  

Webinar | Quality in Treatment

On February 23rd, ISSUP Global presented their Webinar on the topic of quality in substance use disorder treatment. This event tied in with the launch of the new 'Quality in Treatment' Network. Details on how you can register to join the network can be found here: https://www.issup.net/training/quality-treatment

 

This Webinar aimed to increase knowledge of;

  • What quality in treatment is
  • Why quality in treatment is important
  • International initiatives relating to quality in SUD treatment
  • Current or ex-service user role in assuring treatment quality

The webinar also aims to encourage participants to join the new Quality in Treatment network and share good practice.

Speakers:

Annette Dale-Perera

Annette Dale-Perera (chair) - "Introduction to the seminar and the new forum Quality in Treatment"

Annette is the Director of adpconsultancy, consultant to UNODC/WHO and Colombo Plan on quality assurance. She has over 35 years experience in substance use disorder treatment as a practitioner, manager, academic, policy maker and national lead in quality.

 

 

Charlotte SissonCharlotte Sisson - “Why Quality in Treatment is Important”

Charlotte Sisson is a Senior Foreign Affairs Officer within the Office of Global Programs & Policy in the Bureau for International Narcotics and Law Enforcement Affairs at the U.S. Department of State.

 

 

 

 

Anja Busse

Anja Busse - “Overview of UNODC work on Quality in Treatment’

Anja Busse is a Programme Officer, Prevention, Treatment and Rehabilitation Section, Drug Prevention and Health Branch, United Nations Office on Drugs and Crime.

 

 

 

 

Dr. Auwal Salihu

Dr. Auwal Salihu - “Nigeria Quality Assurance pilot”

Dr Salihu is a consultant psychiatrist and Clinical Director of Aminu Teaching Hospital Kano (Substance Use Disorder services) and Bayero University.

 

 

 

Dr. Akan IbangoDr. Akan Ibango - “Nigeria Quality Assurance pilot”

Dr Akan Ibango is UNODC country project officer for Nigeria. He is also a clinical psychologist and has worked in substance use treatment in countries including the UK.

 

 

 

Borikhan Shaumarov

Borikhan Shaumarov - “Quality Assurance in 5 Central Asia Countries”

Borikhan is the Regional Project Co-ordinator UNODC Central Asia. One of his many projects is leading a programme of work on training and technical support to the five Central Asia countries on quality assurance.

 

 

 

 

Tim Sampey

Tim Sampey - “Why Service Users are critical to Quality in Treatment”  

Tim is the CEO of ‘Build on Belief’ (BoB) a peer-led service in London that supports people with substance use and mental health problems. He has lived-experience of heroin use and treatment and has played a key role in service user involvement and quality assurance in NHS and charitable SUD services in the UK.

Annette Dale-Perera

Dear Quality in Treatment members. Thank you for joining the network. The launch event attracted over 650 people - so there is real interest in Quality. Please help us design the programme of webinars for the coming year - your suggestions would be very helpful. Kind regards. Annette

Fatima Abiola Popoola

I am Fatima Abiola Popoola, I work as a Drug Addiction Counselor at the National Drug Law Enforcement Agency, Nigeria. I believe that treatment should be affordable, available and accessible, I also think that care providers should be involved in quality care that is beneficial to the clients.

United Nations Sustainable Development Goals

The Sustainable Development Goals are a call for action by all countries – poor, rich and middle-income – to promote prosperity while protecting the planet.

They recognize that ending poverty must go hand-in-hand with strategies that build economic growth and address a range of social needs including education, health, social protection, and job opportunities while tackling climate change and environmental protection.

The 17 Goals were adopted by all UN Member States in 2015, as part of the 2030 Agenda for Sustainable Development which set out a 15-year plan to achieve the Goals.

Development of Quality Assurance Mechanism and Tools for drug use Disorders treatment

Following the launch of the UNODC-WHO International Standards for the Treatment of Drug Use Disorders (2016) (“the Standards”), there was a need for new globally applicable tools to ensure a qualified and effective response to drug use disorders (DUDs) around the world.

This work contributes to the achievement of the following United Nations Sustainable Development Goals (SDGs):

3- Good Health and Wellbeing

5- Gender Equality

8- Decent Work and Economic Growth

10- Reduced Inequalities

16- Peace, Justice and Strong Institutions

17- Partnership for the Goals

EMCDDA Treatment Standards and Best Practice

Discover what works (and what doesn't work) in the areas of drug prevention, treatment and social reintegration.

The Best Practice Portal of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is a resource for people working in the area of drug-related interventions.

The resource offers information on the available evidence on drug-related prevention and treatment, focusing on the European context. The evidence is compiled following an explicit methodological process. The portal also offers an overview of the available quality standards and guidelines in the European Union member states.

The portal will be continuously updated as information and research on interventions emerges.

Click here to access the portal.

COPOLAD Treatment Work

Since the adoption of the first European Drug Strategy 2000–2004, the EU clearly defines drug-related problems as primarily being a Public Health issue. This approach was also endorsed recently by the Community of Latin American and Caribbean States (CELAC) countries through the OAS Hemispheric drug strategy 2011–15. In both cases, DDR policies are considered essential to develop a balanced approach in the field of drug policy. The implementation of such a balance is still a challenge for the CELAC region.

COPOLAD brings a unique opportunity to support the CELAC region in the practical implementation of models and principles which are well established in the EU for more than three decades now, in countries that had to face huge challenges and have a good record of successes.

Cooperation, coordination and promotion of synergies will continue with actions in DDR developed by the EMCDDA, the CICAD, the PAHO (Pan-American Health Organisation, World Health Organisation (WHO) office for the Americas), the UNODC (United Nations Office on Drugs and Crime) and bi-regional networks of NGOs: RIOD and IDPC. Also, and as started during the first phase, the coordination with other EU funded DDR programmes will be maintained.